155 related articles for article (PubMed ID: 11181399)
1. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms.
Dubey RK; Jackson EK
Am J Physiol Renal Physiol; 2001 Mar; 280(3):F365-88. PubMed ID: 11181399
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular protective effects of 17beta-estradiol metabolites.
Dubey RK; Jackson EK
J Appl Physiol (1985); 2001 Oct; 91(4):1868-83. PubMed ID: 11568174
[TBL] [Abstract][Full Text] [Related]
3. Rapid estrogen actions in the cardiovascular system.
Simoncini T; Mannella P; Genazzani AR
Ann N Y Acad Sci; 2006 Nov; 1089():424-30. PubMed ID: 17261785
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular pharmacology of estradiol metabolites.
Dubey RK; Tofovic SP; Jackson EK
J Pharmacol Exp Ther; 2004 Feb; 308(2):403-9. PubMed ID: 14657266
[TBL] [Abstract][Full Text] [Related]
5. The PI3K/Akt pathway mediates the nongenomic cardioprotective effects of estrogen following trauma-hemorrhage.
Yu HP; Hsieh YC; Suzuki T; Choudhry MA; Schwacha MG; Bland KI; Chaudry IH
Ann Surg; 2007 Jun; 245(6):971-7. PubMed ID: 17522524
[TBL] [Abstract][Full Text] [Related]
6. [Hormonal supplement therapy in women: effects on the cardiovascular system].
Maas AH; van Gilst WH; Verheugt FW
Ned Tijdschr Geneeskd; 2001 Jan; 145(2):65-9. PubMed ID: 11225258
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin and toxicity: recent findings and future challenges.
Vasileiou I; Patsouras D; Patsouris E; Theocharis S
J Appl Toxicol; 2013 Apr; 33(4):238-45. PubMed ID: 22887052
[TBL] [Abstract][Full Text] [Related]
8. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
[TBL] [Abstract][Full Text] [Related]
9. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
[TBL] [Abstract][Full Text] [Related]
10. [Effects of estrogens on the vascular wall: cellular and molecular mechanisms].
Joswig M
Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):189-93. PubMed ID: 10802892
[TBL] [Abstract][Full Text] [Related]
11. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
Dubey RK; Imthurn B; Barton M; Jackson EK
Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
[TBL] [Abstract][Full Text] [Related]
12. Regulation of endothelial nitric oxide synthase and high-density lipoprotein quality by estradiol in cardiovascular pathology.
Kypreos KE; Zafirovic S; Petropoulou PI; Bjelogrlic P; Resanovic I; Traish A; Isenovic ER
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):256-68. PubMed ID: 24414281
[TBL] [Abstract][Full Text] [Related]
13. A novel, nongenomic action of estrogen on the cardiovascular system.
Komesaroff PA; Black CV; Westerman RA
J Clin Endocrinol Metab; 1998 Jul; 83(7):2313-6. PubMed ID: 9661601
[TBL] [Abstract][Full Text] [Related]
14. Receptor-dependent and genomic-independent actions of estrogen in vascular protection.
Lau YT
Chang Gung Med J; 2002 Oct; 25(10):636-44. PubMed ID: 12518775
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone replacement therapy and the vascular wall: mechanisms of 17 beta-estradiol's effects on vascular biology.
Joswig M; Hach-Wunderle V; Ziegler R; Nawroth PP
Exp Clin Endocrinol Diabetes; 1999; 107(8):477-87. PubMed ID: 10612478
[TBL] [Abstract][Full Text] [Related]
16. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications].
Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z
Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507
[TBL] [Abstract][Full Text] [Related]
17. Structure-function relationship of estrogen receptors in cardiovascular pathophysiological models.
Arnal JF; Valéra MC; Payrastre B; Lenfant F; Gourdy P
Thromb Res; 2012 Oct; 130 Suppl 1():S7-11. PubMed ID: 23026669
[TBL] [Abstract][Full Text] [Related]
18. [The effect of water-soluble steroids on the cardiovascular system].
Matiushin AI; Levandovskiĭ IV
Eksp Klin Farmakol; 1994; 57(6):29-31. PubMed ID: 7756953
[TBL] [Abstract][Full Text] [Related]
19. Diabetes modulates differentially creatine kinase-specific activity responsiveness to estradiol-17beta and to raloxifene in rat organs.
Somjen D; Shen M; Stern N; Mirsky N
J Cell Biochem; 2006 Sep; 99(1):133-9. PubMed ID: 16598752
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular responses to apelin in two-kidney-one-clip hypertensive rats and its receptor expression in ischemic and non-ischemic kidneys.
Soltani Hekmat A; Najafipour H; Nekooian AA; Esmaeli-Mahani S; Javanmardi K
Regul Pept; 2011 Dec; 172(1-3):62-8. PubMed ID: 21911011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
